TMEM106B and frontotemporal dementia: In this study, we aimed to investigate the modifying effects of TMEM106B in the largest collection of patients with systematically ascertained FTD and families from the ARTFL/LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) study, on gray matter volume and cognitive measures.